Repligen (RGEN) Restructuring Costs (2012 - 2026)
Repligen (RGEN) posted quarterly Restructuring Costs of $2.7 million for Q2 2026, up 25.72% year-over-year from $2.2 million in Q2 2025, and up 81.68% quarter-over-quarter from $1.5 million in Q1 2026.
Repligen (RGEN) Restructuring Costs (2012 - 2026) Analysis & Trends
Repligen (RGEN) has reported Restructuring Costs for 5 consecutive years, with $2.7 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Restructuring Costs rose 25.72% year-over-year to $2.7 million; the TTM figure through Jun 2026 stood at $8.3 million (up 37.09% YoY), while the FY2014 annual figure was $1.9 million, up 2032.89% from the prior year.
- Restructuring Costs climbed to $2.7 million in Q2 2026 per RGEN's latest filing, from $1.5 million in the prior quarter.
- Across five years, Restructuring Costs topped out at $2.7 million in Q2 2026 and bottomed at $1.5 million in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.49 Bn | 129.28 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.54 Bn | 51.67 Bn | 2.32 Bn |
| 3 | Alcon | 35.71 Bn | 34.35 Bn | 1.68 Bn |
| 4 | Resmed | 33.80 Bn | 32.33 Bn | 861.22 Mn |
| 5 | Medline | 29.08 Bn | 26.40 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 24.96 Bn | 24.52 Bn | 329.20 Mn |
| 7 | Solventum | 15.40 Bn | 15.00 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.82 Bn | 14.68 Bn | 735.40 Mn |
| 9 | Baxter International | 13.61 Bn | 11.46 Bn | 1.03 Bn |
| 10 | Repligen | 10.22 Bn | 9.21 Bn | 110.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.72 Mn |
| Mar 31, 2026 | 1.50 Mn |
| Jun 30, 2025 | 2.16 Mn |
| Mar 31, 2025 | 1.97 Mn |
| Dec 31, 2014 | 1.95 Mn |
| Sep 30, 2014 | 10,000.00 |
| Jun 30, 2014 | 18,000.00 |
| Mar 31, 2014 | 98,000.00 |
| Dec 31, 2013 | 45,000.00 |
| Sep 30, 2013 | 65,000.00 |
| Jun 30, 2013 | 35,000.00 |
| Mar 31, 2013 | -54,000.00 |
| Dec 31, 2012 | 267,000.00 |
| Sep 30, 2012 | 344,000.00 |